These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12888267)

  • 21. Bis(maltolato)oxovanadium(IV) (BMOV) Attenuates Apoptosis in High Glucose-Treated Cardiac Cells and Diabetic Rat Hearts by Regulating the Unfolded Protein Responses (UPRs).
    Cong XQ; Piao MH; Li Y; Xie L; Liu Y
    Biol Trace Elem Res; 2016 Oct; 173(2):390-8. PubMed ID: 26983714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic rats.
    Yuen VG; Orvig C; McNeill JH
    Am J Physiol; 1997 Jan; 272(1 Pt 1):E30-5. PubMed ID: 9038848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV).
    Yuen VG; Orvig C; Thompson KH; McNeill JH
    Can J Physiol Pharmacol; 1993; 71(3-4):270-6. PubMed ID: 8402391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bis(maltolato)oxovanadium(IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats.
    Bhanot S; Bryer-Ash M; Cheung A; McNeill JH
    Diabetes; 1994 Jul; 43(7):857-61. PubMed ID: 8013747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo effects of vanadium in diabetic rats are independent of changes in PI-3 kinase activity in skeletal muscle.
    Mohammad A; Bhanot S; McNeill JH
    Mol Cell Biochem; 2001 Jul; 223(1-2):103-8. PubMed ID: 11681710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers.
    Saatchi K; Thompson KH; Patrick BO; Pink M; Yuen VG; McNeill JH; Orvig C
    Inorg Chem; 2005 Apr; 44(8):2689-97. PubMed ID: 15819554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of bis(maltolato) oxovanadium (IV) on protein serine kinases in skeletal muscle of streptozotocin-diabetic rats.
    Bhanot S; Girn J; Poucheret P; McNeill JH
    Mol Cell Biochem; 1999 Dec; 202(1-2):131-40. PubMed ID: 10706003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors. Redox independent activation of NF-kappaB.
    Krejsa CM; Nadler SG; Esselstyn JM; Kavanagh TJ; Ledbetter JA; Schieven GL
    J Biol Chem; 1997 Apr; 272(17):11541-9. PubMed ID: 9111069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bis(maltolato)oxovanadium(IV) Induces Angiogenesis via Phosphorylation of VEGFR2.
    Parma L; Peters HAB; Johansson ME; Gutiérrez S; Meijerink H; de Kimpe S; de Vries MR; Quax PHA
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B.
    Han H; Lu L; Wang Q; Zhu M; Yuan C; Xing S; Fu X
    Dalton Trans; 2012 Aug; 41(36):11116-24. PubMed ID: 22864521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition protein tyrosine phosphatases by an oxovanadium glutamate complex, Na2[VO(Glu)2(CH3OH)](Glu = glutamate).
    Lu L; Wang S; Zhu M; Liu Z; Guo M; Xing S; Fu X
    Biometals; 2010 Dec; 23(6):1139-47. PubMed ID: 20617368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lineage-specific induction of B cell apoptosis and altered signal transduction by the phosphotyrosine phosphatase inhibitor bis(maltolato)oxovanadium(IV).
    Schieven GL; Wahl AF; Myrdal S; Grosmaire L; Ledbetter JA
    J Biol Chem; 1995 Sep; 270(35):20824-31. PubMed ID: 7657667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A polymer-based drug delivery system for the antineoplastic agent bis(maltolato)oxovanadium in mice.
    Jackson JK; Min W; Cruz TF; Cindric S; Arsenault L; Von Hoff DD; Degan D; Hunter WL; Burt HM
    Br J Cancer; 1997; 75(7):1014-20. PubMed ID: 9083337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-enhancing vanadium(III) complexes.
    Melchior M; Rettig SJ; Liboiron BD; Thompson KH; Yuen VG; McNeill JH; Orvig C
    Inorg Chem; 2001 Aug; 40(18):4686-90. PubMed ID: 11511216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tyrosine phosphatase inhibitor bis(maltolato)oxovanadium attenuates myocardial reperfusion injury by opening ATP-sensitive potassium channels.
    Liem DA; Gho CC; Gho BC; Kazim S; Manintveld OC; Verdouw PD; Duncker DJ
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1256-62. PubMed ID: 14993257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds: pyridine-2,6-dicarboxylatodioxovanadium(V), BMOV, and an amavadine analogue.
    Aureliano M; Henao F; Tiago T; Duarte RO; Moura JJ; Baruah B; Crans DC
    Inorg Chem; 2008 Jul; 47(13):5677-84. PubMed ID: 18510311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and chronic oral administration of bis(maltolato)oxovanadium(IV) in Zucker diabetic fatty (ZDF) rats.
    Yuen VG; Vera E; Battell ML; Li WM; McNeill JH
    Diabetes Res Clin Pract; 1999 Jan; 43(1):9-19. PubMed ID: 10199584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
    Dabroś W; Dziga D; Kordowiak AM
    Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of in vitro interactions of protein tyrosine phosphatase 1B with insulin receptors.
    Wang XY; Bergdahl K; Heijbel A; Liljebris C; Bleasdale JE
    Mol Cell Endocrinol; 2001 Feb; 173(1-2):109-20. PubMed ID: 11223182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The vanadyl (VO2+) chelate bis(acetylacetonato)oxovanadium(IV) potentiates tyrosine phosphorylation of the insulin receptor.
    Ou H; Yan L; Mustafi D; Makinen MW; Brady MJ
    J Biol Inorg Chem; 2005 Dec; 10(8):874-86. PubMed ID: 16235045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.